Search details
1.
Prognostication in Lymph Node-Positive Prostate Cancer with No PSA Persistence After Radical Prostatectomy.
Ann Surg Oncol
; 31(6): 3872-3879, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38353798
2.
Assessing antiviral treatment efficacy and risk factors for severe COVID-19 in kidney transplant recipients during the Omicron subvariant-dominant period: a retrospective study.
BMC Nephrol
; 25(1): 124, 2024 Apr 08.
Article
in English
| MEDLINE | ID: mdl-38589827
3.
GnRH antagonist monotherapy versus a GnRH agonist plus bicalutamide for advanced hormone-sensitive prostate cancer; KYUCOG-1401.
Int J Urol
; 31(4): 362-369, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38148124
4.
Clinicopathological characteristics of adrenocortical carcinoma in the Kyushu-Okinawa area of Japan.
Int J Urol
; 31(5): 484-491, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38193650
5.
Summary of the Clinical Practice Guidelines for Upper Tract Urothelial Carcinoma 2023 by the Japanese Urological Association.
Int J Urol
; 31(3): 194-207, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38113344
6.
Potential therapeutic target secretogranin II might cooperate with hypoxia-inducible factor 1α in sunitinib-resistant renal cell carcinoma.
Cancer Sci
; 114(10): 3946-3956, 2023 Oct.
Article
in English
| MEDLINE | ID: mdl-37545017
7.
Real-world treatment outcomes of patients with penile cancer in the Kyushu-Okinawa area of Japan in the pre-guideline era.
Jpn J Clin Oncol
; 53(9): 837-844, 2023 Aug 30.
Article
in English
| MEDLINE | ID: mdl-37282601
8.
Validation of the risk stratification newly defined in the Japanese Urological Association guidelines 2019 for non-muscle invasive bladder cancer: A multi-institutional collaborative study.
Int J Urol
; 30(5): 473-481, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36788781
9.
Radiotherapy plus androgen deprivation therapy for prostate-specific antigen persistence in lymph node-positive prostate cancer.
Cancer Sci
; 113(7): 2386-2396, 2022 Jul.
Article
in English
| MEDLINE | ID: mdl-35485635
10.
Exosomal microRNA-1 and MYO15A as a target for therapy and diagnosis in renal cell carcinoma.
Biochem Biophys Res Commun
; 630: 71-76, 2022 11 19.
Article
in English
| MEDLINE | ID: mdl-36150242
11.
Targeting of the glutamine transporter SLC1A5 induces cellular senescence in clear cell renal cell carcinoma.
Biochem Biophys Res Commun
; 611: 99-106, 2022 06 30.
Article
in English
| MEDLINE | ID: mdl-35487063
12.
Efficacy of combined androgen blockade therapy in patients with metastatic hormone-sensitive prostate cancer stratified by tumor burden.
Int J Urol
; 29(5): 398-405, 2022 05.
Article
in English
| MEDLINE | ID: mdl-35080069
13.
Novel metastatic burden-stratified risk model in de novo metastatic hormone-sensitive prostate cancer.
Cancer Sci
; 112(9): 3616-3626, 2021 Sep.
Article
in English
| MEDLINE | ID: mdl-34145921
14.
Differential prognostic factors in low- and high-burden de novo metastatic hormone-sensitive prostate cancer patients.
Cancer Sci
; 112(4): 1524-1533, 2021 Apr.
Article
in English
| MEDLINE | ID: mdl-33159829
15.
EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer.
BMC Cancer
; 21(1): 48, 2021 Jan 11.
Article
in English
| MEDLINE | ID: mdl-33430801
16.
Potential new therapy of Rapalink-1, a new generation mammalian target of rapamycin inhibitor, against sunitinib-resistant renal cell carcinoma.
Cancer Sci
; 111(5): 1607-1618, 2020 May.
Article
in English
| MEDLINE | ID: mdl-32232883
17.
Oncological outcome of neoadjuvant low-dose estramustine plus LHRH agonist/antagonist followed by extended radical prostatectomy for Japanese patients with high-risk localized prostate cancer: a prospective single-arm study.
Jpn J Clin Oncol
; 50(1): 66-72, 2020 Jan 24.
Article
in English
| MEDLINE | ID: mdl-31665352
18.
A new risk stratification model for intravesical recurrence, disease progression, and cancer-specific death in patients with non-muscle invasive bladder cancer: the J-NICE risk tables.
Int J Clin Oncol
; 25(7): 1364-1376, 2020 Jul.
Article
in English
| MEDLINE | ID: mdl-32232691
19.
Pembrolizumab versus chemotherapy in recurrent, advanced urothelial cancer in Japanese patients: a subgroup analysis of the phase 3 KEYNOTE-045 trial.
Int J Clin Oncol
; 25(1): 165-174, 2020 Jan.
Article
in English
| MEDLINE | ID: mdl-31729625
20.
Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer.
Br J Cancer
; 118(6): e7, 2018 03 20.
Article
in English
| MEDLINE | ID: mdl-29438376